INO
Inovio Pharmaceuticals Inc
Price:  
2.19 
USD
Volume:  
1,060,675.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO EV/EBITDA

-2830.4%
Upside

As of 2025-02-19, the EV/EBITDA ratio of Inovio Pharmaceuticals Inc (INO) is -0.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INO's latest enterprise value is 57.26 mil USD. INO's TTM EBITDA according to its financial statements is -119.63 mil USD. Dividing these 2 quantities gives us the above INO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.6x - 15.8x 15.3x
Forward P/E multiples 16.8x - 23.3x 21.1x
Fair Price (55.28) - (51.96) (59.80)
Upside -2624.3% - -2472.8% -2830.4%
2.19 USD
Stock Price
(59.80) USD
Fair Price

INO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-18 -0.48
2025-02-14 -0.47
2025-02-13 -0.46
2025-02-12 -0.46
2025-02-11 -0.39
2025-02-10 -0.40
2025-02-07 -0.41
2025-02-06 -0.42
2025-02-05 -0.43
2025-02-04 -0.42
2025-02-03 -0.42
2025-01-31 -0.45
2025-01-30 -0.45
2025-01-29 -0.43
2025-01-28 -0.48
2025-01-27 -0.50
2025-01-24 -0.48
2025-01-23 -0.51
2025-01-22 -0.50
2025-01-21 -0.48
2025-01-17 -0.45
2025-01-16 -0.39
2025-01-15 -0.38
2025-01-14 -0.38
2025-01-13 -0.39
2025-01-10 -0.42
2025-01-08 -0.45
2025-01-07 -0.51
2025-01-06 -0.40
2025-01-03 -0.41
2025-01-02 -0.37
2024-12-31 -0.37
2024-12-30 -0.36
2024-12-27 -0.38
2024-12-26 -0.38
2024-12-24 -0.37
2024-12-23 -0.36
2024-12-20 -0.37
2024-12-19 -0.37
2024-12-18 -0.36
2024-12-17 -0.41
2024-12-16 -0.47
2024-12-13 -0.52
2024-12-12 -0.95
2024-12-11 -1.03
2024-12-10 -1.03
2024-12-09 -1.07
2024-12-06 -1.08
2024-12-05 -1.03
2024-12-04 -1.06